Search

The purpose of this study was to compile a comprehensive characterization of little-known polypores, which have recently been found to possess anticancer activity and thus can also be used in cancer target therapy. Haploporus odorus is a polypore of Holarctic distribution and has been found by harvesters working in taiga floodlands and broadleaf forests of the Northern Hemisphere. A substance known as haploporic acid A was determined in methylene chloride extract from the dried basidiomata of H. odorus. This substance can be used in cancer therapy; more details of its health benefits could be used in mycotherapy.

The purpose of this study was to comprehensively characterize little-known polypores that have recently been found to possess anticancer activity and thus can be used in targeted cancer therapy. Funalia trogii is a polypore with bipolar distribution and has been found by harvesters working in taiga forests, broadleaf forests, and forest-steppes of the Holarctic, and in semiarid temperate forests of the Southern Hemisphere. Substances such as gibberellic acid, abscisic acid, indole-3-acetic acid, and natural cytokinin were determined in culture media of F. trogii. Also, laccases and peroxidases of spare action have been reported in F. trogii culture media. All of the aforementioned substances can be used in targeted cancer therapy, but further investigation of F. trogii is recommended; more details of its health benefits could expand its use in mycotherapy.

The purpose of this study was to comprehensively characterize a little-known polypore that has recently been found to possess anticancer activity and thus can also be used in targeted cancer therapy. Earliella scabrosa is a polypore with pantropical distribution and can be found in rainforests in both the Eastern and Western Hemispheres. Some reports have described its antioxidant properties and free radical scavenging ability. Moreover, isocoumarin, which has been successfully used in targeted cancer therapy, was found in extracts of this fungus. We recommend further research of E. scabrosa so that more details of its health benefits could be used in mycotherapy.

The present paper summarizes morphological, taxonomical, and biodiversity information on the important medicinal mushroom genus Trametes on a global scale. An identification key enriched by sufficient morphological descriptions is given for 64 recognized species of this genus. Each species is characterized in its global distribution and also in current or potential medicinal use. Thirteen new combinations were made as follows: Trametes apiaria (Pers.) Zmitr., Wasser & Ezhov; T. flavida (Lev.) Zmitr., Wasser & Ezhov; T. glabrorigens (Lloyd) Zmitr., Wasser & Ezhov; T. hirta (P. Beauv.) Zmitr., Wasser & Ezhov; T. hostmannii (Berk.) Zmitr., Wasser & Ezhov; T. niam-niamensis (P. Henn.) Zmitr., Wasser & Ezhov; T. quarrei (Beeli) Zmitr., Wasser & Ezhov; T. speciosa (Fr.) Zmitr., Wasser & Ezhov; T. strumosa (Fr.) Zmitr., Wasser & Ezhov; T. variegata (Berk.) Zmitr., Wasser & Ezhov; T. vernicipes (Berk.) Zmitr., Wasser & Ezhov; T. vespacea (Pers.) Zmitr., Wasser & Ezhov; and T. warnieri (Durieu & Mont.) Zmitr., Wasser & Ezhov.